Keywords: Conformation-dependent epitope; Antibody mediated disease; Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG)ACh, acetylcholine; AChBP, acetylcholine binding protein; B-132A, biotinylated mAb 132A; cDNA, double stranded DNA complemen
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients
Keywords: Myasthenia gravis (MG); Acetylcholine receptor antibody; Muscle-specific tyrosine kinase antibody; Double-seropositive myasthenia gravis (DSP-MG);
miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells
Keywords: Myasthenia gravis (MG); Thymus hyperplasia; miR-548k; CXCL13;
Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells
Keywords: Myasthenia gravis (MG); Thymoma; MiR-125a-5p; Foxp3;
Collagen Q – A potential target for autoantibodies in myasthenia gravis
Keywords: Collagen Q (COLQ); Myasthenia gravis (MG); Neuromuscular junction (NMJ); Cell-based assay (CBA); Autoantibodies; Neuroimmunology
The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis
Keywords: CD21; Acetylcholine receptor (AchR); B cells; Myasthenia gravis (MG); Autoimmunity; Pathogenesis
Proton magnetic resonance spectroscopy of the intrinsic tongue muscles in patients with myasthenia gravis with different autoantibodies
Keywords: Myasthenia gravis (MG); Acetylcholine receptor (AChR); Muscle-specific kinase (MuSK); Proton magnetic resonance spectroscopy (MRS); Intrinsic tongue muscles;
Evaluation and Treatment of Stage I and II Thymoma
Keywords: Thymoma; Myasthenia gravis (MG); Surgical resection; Adjuvant radiotherapy
Involvement of phosphodiesterases in autoimmune diseases
Keywords: Phosphodiesterases (PDE); Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG); Experimental allergic encephalomyelitis (EAE); Multiple sclerosis (MS)
Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-γ inducible protein 10 (IP-10) and its receptor CXCR3
Keywords: Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG); IFN-γ inducible protein 10 (IP-10); CXCR3; Immunosuppression
Serum BAFF expression in patients with myasthenia gravis
Keywords: BAFF; B lymphocyte stimulator; Myasthenia gravis (MG)
Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent
Keywords: Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG); Combined therapy; Solumedrol; Pentoxifylline
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis
Keywords: IVIG (intravenous immunoglobulin) therapy; Disease-specific anti-antibodies; Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG)
Double Vision in a Patient with Thyroid Disease: What's the Big Deal?
Keywords: diplopia; exotropia; Graves disease; myasthenia gravis (MG); strabismus; thyroid-related orbitopathy;
Lineage tree analysis of immunoglobulin variable-region gene mutations in autoimmune diseases: Chronic activation, normal selection
Keywords: Germinal centers; Somatic hypermutation; Myasthenia Gravis (MG); Rheumatoid Arthritis (RA); Sjögren’s Syndrome (SS)
A sensitive non-isotopic assay for acetylcholine receptor autoantibodies
Keywords: Myasthenia gravis (MG); Acetylcholine receptor (AChR); Autoantibodies (Ab); ELISA
Intravenous immunoglobulin suppresses experimental myasthenia gravis: Immunological mechanisms
Keywords: Myasthenia gravis (MG); Experimental autoimmune myasthenia gravis (EAMG); Intravenous immunoglobulins (IVIG); Immunomodulation;